Sunshine Biopharma Inc.
SBFM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001402328
No open-market purchases or sales by Sunshine Biopharma Inc. insiders were filed in the last 90 days; 9 institutions reported holding it in 13F filings for Q2 2026, worth $32.6K in total; no superinvestor holds it.
Other share classesSBFMW
Holders of 5% or more of SBFM
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Sunshine Biopharma Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Intracoastal Capital, LLC | 13G | 9.99%505.7K shares | New | May 23, 20251 filing | May 23, 2025 | SEC |
| Intracoastal Capital, LLC | 13G/A | 9.99%235.7K shares | – | Aug 13, 20261 filing | Aug 13, 2026 | SEC |
| Bigger Capital Fund L P | 13G | 9.47%1.61M shares | +9.47 ppfrom 0.00% | Apr 11, 20253 filings | May 21, 2026 | SEC |
| Alta Partners LLC | 13G | 8.60%200.0K shares | New | Jul 8, 20261 filing | Jul 8, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
11 Schedule 13D and 13G filings on Sunshine Biopharma Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Aug 14, 20264:10 PM ET | L1 Capital Global Opportunities Master Fund, Ltd. | 13G/A | 4.99%111.5K shares | −0.84 ppfrom 5.83%Below 5% | Aug 14, 2026 | SEC |
| Aug 13, 202610:21 AM ET | Intracoastal Capital, LLCand 2 others | 13G/A | 9.99%235.7K shares | – | Jun 30, 2026 | SEC |
| Jul 8, 20266:05 PM ET | Alta Partners LLC | 13G | 8.60%200.0K shares | New | Jul 8, 2026 | SEC |
| May 22, 20264:10 PM ET | L1 Capital Global Opportunities Master Fund, Ltd. | 13G | 5.83%1.00M shares | New | May 18, 2026 | SEC |
| May 21, 20264:16 PM ET | Bigger Capital Fund L Pand 6 others | 13G | 9.47%1.61M shares | +9.47 ppfrom 0.00% | May 18, 2026 | SEC |
| Aug 14, 202510:35 AM ET | Altium Capital Management LPand 2 others | 13G/A | 0.00%0 shares | –Below 5% | Jun 30, 2025 | SEC |
| Jun 12, 20258:24 PM ET | Bigger Capital Fund L Pand 2 others | 13G/A | 0.00%0 shares | −8.17 ppfrom 8.17%Below 5% | Jun 10, 2025 | SEC |
| May 23, 20254:17 PM ET | Intracoastal Capital, LLCand 2 others | 13G | 9.99%505.7K shares | New | May 19, 2025 | SEC |
| Apr 11, 20255:02 PM ET | Bigger Capital Fund L Pand 2 others | 13G | 8.17%297.1K shares | New | Apr 2, 2025 | SEC |
| Feb 14, 20254:43 PM ET | L1 Capital Global Opportunities Master Fund, Ltd. | 13G/A | 4.99%142.2K shares | –Below 5% | Dec 31, 2024 | SEC |
| Jul 29, 2021 | Beathard Robert King 3rd | 13GOld format | – | New | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Sunshine Biopharma Inc. shares.
No Form 144 notices for Sunshine Biopharma Inc. are on file.